2022 - Research.com Best Female Scientist Award
Monica Morrow mainly focuses on Breast cancer, Mastectomy, Surgery, Internal medicine and Oncology. Her Breast cancer study deals with the bigger picture of Cancer. Her research integrates issues of Odds ratio, Radiation therapy, Retrospective cohort study and Stage in her study of Mastectomy.
Her biological study spans a wide range of topics, including Axillary Lymph Node Dissection, Sentinel lymph node, Carcinoma and Sentinel node. Her research investigates the link between Internal medicine and topics such as Endocrinology that cross with problems in Inflammation and Aromatase. The Oncology study combines topics in areas such as Lymphovascular invasion, Risk factors for breast cancer, Estrogen receptor and Mammary gland.
Monica Morrow mostly deals with Breast cancer, Internal medicine, Oncology, Mastectomy and Surgery. Her Breast cancer research is within the category of Cancer. Her research on Internal medicine often connects related areas such as Gynecology.
Her Oncology research is multidisciplinary, incorporating perspectives in Neoadjuvant therapy, Lymphovascular invasion, Survival rate, Tamoxifen and Estrogen receptor. Monica Morrow has included themes like Breast surgery, Carcinoma and Retrospective cohort study in her Mastectomy study. Her Surgery study also includes
Her main research concerns Breast cancer, Internal medicine, Mastectomy, Surgical oncology and Oncology. Her Breast cancer research includes themes of Stage, Surgery and Chemotherapy. Monica Morrow works mostly in the field of Internal medicine, limiting it down to concerns involving Gastroenterology and, occasionally, Concordance and Incidence.
Monica Morrow combines subjects such as Odds ratio, Lymphovascular invasion, Breast reconstruction, Ketorolac and Ductal carcinoma with her study of Mastectomy. Her Surgical oncology study combines topics in areas such as Radiology, General surgery and Increased risk. Her Oncology study incorporates themes from Metaplastic Breast Carcinoma, Radiation therapy and Genetic testing.
Her primary areas of study are Breast cancer, Internal medicine, Mastectomy, Odds ratio and Surgical oncology. Her Breast cancer study is concerned with Cancer in general. Monica Morrow has researched Cancer in several fields, including Tertiary care and Proportional hazards model.
As part of one scientific family, Monica Morrow deals mainly with the area of Internal medicine, narrowing it down to issues related to the Oncology, and often Radiation therapy and Genetic testing. The study incorporates disciplines such as Breast reconstruction, Breast surgery, Surgery and Radiology in addition to Mastectomy. Her Surgical oncology research incorporates themes from Gastroenterology, Chemotherapy and Surgical treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch;E P Winer;A S Coates;R D Gelber.
Annals of Oncology (2013)
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial
Armando E. Giuliano;Kelly K. Hunt;Karla V. Ballman;Peter D. Beitsch.
JAMA (2011)
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
Steven R. Cummings;Stephen Eckert;Kathryn A. Krueger;Deborah Grady.
JAMA (1999)
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett.
Journal of Clinical Oncology (2002)
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Armando E. Giuliano;Linda McCall;Peter Beitsch;Pat W. Whitworth.
Annals of Surgery (2010)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano;Karla V. Ballman;Linda McCall;Peter D. Beitsch.
JAMA (2017)
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial.
J. A. Cauley;L. Norton;M. E. Lippman;S. Eckert.
Breast Cancer Research and Treatment (2001)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant.
Annals of Oncology (2017)
Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and II invasive breast cancer
Meena S. Moran;Stuart J. Schnitt;Armando E. Giuliano;Jay R. Harris.
Annals of Surgical Oncology (2014)
Factors Predicting the Use of Breast-Conserving Therapy in Stage I and II Breast Carcinoma
Monica Morrow;Julia White;Jennifer Moughan;Jean Owen.
Journal of Clinical Oncology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Cornell University
Brigham and Women's Hospital
Cedars-Sinai Medical Center
University of Sydney
Memorial Sloan Kettering Cancer Center
Georgetown University
Osaka University
University of Pennsylvania
Yonsei University
Jilin University
Arc International
Lawrence Berkeley National Laboratory
Harvard University
Stanford University
JNC (Japan)
Cincinnati Children's Hospital Medical Center
Spanish National Research Council
Centers for Disease Control and Prevention
Oregon Health & Science University
Leiden University Medical Center
Duke University
Southwest Research Institute